Accessibility Menu
Tanke Biosciences logo

Tanke Biosciences(OTC) TNBI

Market Cap$368.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-99%
5 Year-99%
1 Year-64%
1 Month-63%
$0.02
+0.00%
+0.00Today
Tanke Biosciences last closing stock price
MetricPriceDate
Last closeUSD 0.022026-06-02
Tanke Biosciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.022026-05-08
1 month-62.78%USD 0.042026-04-15
3 month-69.22%USD 0.052026-03-03
Year to date-42.97%USD 0.032025-12-31
1 year-64.29%USD 0.042025-05-27
3 year-88.45%USD 0.132023-05-26
5 year-99.06%USD 1.602021-06-03
Since inception-98.51%USD 1.012011-06-07

Tanke Biosciences Financials at a Glance

Market Cap

$368.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.43K

Net Income (TTM)

-$213.82K

EPS (TTM)

-$0.01

P/E Ratio

-1.79

Dividend

$0.00

Beta (Volatility)

-0.21 (Low)

Price

$0.02

Volume

5

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.06

Estimated Earnings Date

N/A

TNBI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tanke Biosciences

Tanke Biosciences Corporation is focused on developing, producing, and selling a diverse range of animal nutrition and feed additive products. The company operates through various subsidiaries and offers products that cater to livestock and poultry markets, primarily in China, Southeast Asia, and Latin America.

Products and Services
  • Organic trace mineral additives marketed under the Qili brand
  • Qilicid feed acidifiers to prevent microbial spoilage
  • Herbal medicinal additives like Extra-Health and Qilimix
Growth Outlook
  • Expansion into Southeast Asia and Latin America is underway
  • Increasing demand for organic and herbal feed additives
  • Focus on enhancing product portfolio to meet market needs
Financial Highlights
  • Recent quarterly net income of -38,336, reflecting ongoing operational challenges
  • Trailing twelve months (TTM) revenue of 0, indicating a need for strategic growth initiatives
  • Current ratio of 0.027, highlighting liquidity concerns
Tanke Biosciences Corporation has established itself in the animal nutrition sector, offering a variety of products designed to enhance livestock health and productivity. The company's focus on organic and herbal solutions aligns with growing consumer preferences for sustainable and natural products. Despite facing financial challenges, including negative net income and low liquidity ratios, Tanke Biosciences is positioned to capitalize on emerging market opportunities. The ongoing expansion efforts in Southeast Asia and Latin America, coupled with a commitment to product innovation, may provide pathways for future growth. Investors may find interest in the company's potential to adapt and thrive in a competitive landscape.
AI Generated • Jul 17, 2026

Industry

Commercial Services and Supplies

Sector

Industrials

CEO

Vincent W. Renz, Jr., MBA

Website

www.tanke-bio.com

Headquarters

Las Vegas, NV 89128, US

TNBI Financials

Key Financial Metrics (TTM)

Gross Margin

88.39%

Operating Margin

-2390.21%

Net Income Margin

-2536.41%

Return on Equity

58.00%

Return on Capital

N/A

Return on Assets

-274.08%

Earnings Yield

-55.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$368.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

24.54M

Volume

5

Avg. Volume

198.492

Financials (TTM)

Gross Profit

$7.45K

Operating Income

-$201.50K

EBITDA

-$202.22K

Operating Cash Flow

-$25.40K

Capital Expenditure

$7.84

Free Cash Flow

-$25.39K

Cash & ST Invst.

$9.56K

Total Debt

$140.00K

Tanke Biosciences Performance Analysis

Tanke Biosciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 8,430N/A
Tanke Biosciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30-100.0%
Q42025-12-31N/A
Q12026-03-31N/A
Tanke Biosciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.01-86.1%
20232023-12-31USD -0.00-50.6%
20242024-12-31USD -0.005.1%
20252025-12-31USD -0.01163.4%
Tanke Biosciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3033.3%
Q32025-09-307.7%
Q42025-12-3120.8%
Q12026-03-3121.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$368.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.83K

N/A

Employees

130

N/A

Net Income

-$38.34K

+61.2%

EBITDA

-$35.69K

+60.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$9.56K

-75.0%

Total Debt

$140.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$140.00K

+0.0%

Return on Assets

-2.74%

N/A

Return on Invested Capital

46.09%

N/A

Free Cash Flow

-$870.00

-109.2%

Operating Cash Flow

-$869.00

-109.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AIKOAlternative Investment Corporation
$0.98+0.00%
IVFZFMapath Capital Corp
$0.01+0.00%
QYBXQian Yuan Baixing, Inc.
$0.01+0.00%
NGCGNew Generation Consumer Group, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About TNBI

What is the current price of Tanke Biosciences?

Tanke Biosciences is trading at $0.02 per share.

What is the 52-week range for Tanke Biosciences?

Over the past 52 weeks, Tanke Biosciences has traded between $0.02 and $0.06.

How much debt does Tanke Biosciences have?

As of the most recent reporting period, Tanke Biosciences reported total debt of $140.00K.

How much cash does Tanke Biosciences have on hand?

Tanke Biosciences reported $9.56K in cash and cash equivalents in its most recent financial results.

What is Tanke Biosciences’s dividend yield?

Tanke Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services